MBTPS1 and rheumatoid arthritis: Considering S1P’s role in regulating inflammation and immune responses via receptor binding, and its impact on cellular growth and apoptosis, targeting both S1P and its receptor (S1PR) shows therapeutic potential in autoimmune arthritis, as evidenced in RA [52,53].